proliferative lymphadenopathy, lymphoma, tuberculous lymphadenitis, and metastatic lymph nodes.
Conditions
Interventions
malignant lymph nodes:No
Benign lymph node:No
Sponsors
Second Xiangya Hospital of CSU
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Age >= 18 years old; 2. Abnormal cervical lymph nodes found by ultrasound; 3. Routine ultrasound, shear wave elastography, viscoelastic ultrasound imaging, contrast-enhanced ultrasound, and super-resolution contrast-enhanced ultrasound images that can obtain complete and high-quality target lymph nodes; 4. The target lesion has not undergone any related treatment previously, including surgery, ablation, targeted drugs, clinical trial drugs, etc. 5. Capable of understanding and willing to sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Pregnant or breastfeeding women; 2. There may be an allergy to contrast agents or other contraindications. 3. Patients with poor coordination of vascular pulsation, respiratory movement, etc. 4. Patients with a history of prior radiotherapy or chemotherapy; 5. Incomplete clinical data; 6. Refusal to sign the informed consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| super-resolution contrast enhanced ultrasound;Viscoelastic value; | — |
Countries
China
Contacts
Public ContactChengcheng Niu
Second Xiangya Hospital of CSU
Outcome results
None listed